Journal of Medical Economics

Title Publication Date Language Citations
Cost-effectiveness analysis of LungLB for the clinical management of patients with indeterminate pulmonary nodules2023/03/03English
Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England2023/02/07English
A cost-effectiveness analysis of intrauterine spacers used to prevent the formation of intrauterine adhesions following endometrial cavity surgery2023/12/22English
Cost-effectiveness of a novel urethral catheter safety device in preventing catheterization injuries in the UK2024/01/10English
Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes2023/12/13English
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany2023/12/13English
What to expect in 2024: important health economics and outcomes research (HEOR) trends2023/12/20English
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK2024/02/19English
Economic burden of COVID-19 for employers and employees in the United States2024/02/24English
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals2024/02/13English
Variation in access to hemophilia A treatments in the United States2021/01/01English
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and France2022/03/04English
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–6972021/01/01English
Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit?2020/04/29English
Alternative payment models and innovation: a case study of US health system adoption of a sacubitril/valsartan to treat acute decompensated heart failure2020/10/07English
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer2021/01/01English
Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial2021/01/01English
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy2021/01/01English
Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis2021/01/01English
The health economic impact of varying levels of adherence to colorectal screening on providers and payers2021/01/01English
Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China2020/02/24English
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States2017/08/11English
Re: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-7022017/08/11English
Reply: A dynamic approach for outpatient scheduling2017/08/09English
A review of biosimilar in regulations and potential impact: Hong Kong perspectives2019/05/28English
“Clinically nuanced” Medicaid cost-sharing2017/10/21English
The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States2018/08/16English
Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant2018/08/14English
Budget impact analysis of demineralized bone matrix in combination with autograft in lumbar spinal fusion procedures for the treatment of lumbar degenerative disc disease in Spain2018/07/05English
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine2013/03/05English